FDA Approved Dec 23, 2025 First orally given GLP-1 Agonist has just been approved by the FDA! Semaglutide The American Food and Drug Administration (FDA) has just approved the orally given Semaglutide, being sold under the brand name of Wegovy, Novo Nordisk, for the treatment of obesity and maintain weight reduction long... Read full announcement
FDA Approved Oct 09, 2025 Nerandomilast FDA Approval Nerandomilast Today, the FDA has announced that Nerandomilast, being sold under the brand name Jascayd, has just been approved for the treatment of idiopathic pulmonary fibrosis (IPF), which is very rare, serious and progressive... Read full announcement
FDA Approved Sep 30, 2025 Remibrutinib FDA Approval Remibrutinib On 30th of September, 2025, the Food and Drug Administration (FDA) announced that Remibrutinib has been approved for use in chronic spontaneous urticaria (CSU) in adult patients who remain symptomatic despite... Read full announcement